Stockscreener 앱 받기
2.93
6.16%
0.17
시간 외 거래:
2.88
-0.05
-1.71%
전일 마감가:
$2.76
열려 있는:
$2.73
하루 거래량:
469.80K
Relative Volume:
2.28
시가총액:
$108.60M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-9.7667
EPS:
-0.3
순현금흐름:
$-18.01M
1주 성능:
+21.07%
1개월 성능:
+132.60%
6개월 성능:
+161.61%
1년 성능:
+265.79%
1일 변동 폭
$2.62
$3.01
1주일 범위
$2.155
$3.15
52주 변동 폭
$0.7001
$3.15
Estrella Immunopharma Inc Stock (ESLA) Company Profile
명칭
Estrella Immunopharma Inc
전화
(510) 318-9098
주소
5858 HORTON STREET, SUITE 370, EMERYVILLE
ESLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
2.93 | 102.30M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
How to integrate Estrella Immunopharma Inc. into portfolio analysis toolsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - newser.com
What data driven models say about Estrella Immunopharma Inc.’s futurePortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com
Estrella Immunopharma Achieves Milestone in STARLIGHT-1 Trial - TipRanks
[8-K] Estrella Immunopharma, Inc. Reports Material Event | ESLA SEC FilingForm 8-K - Stock Titan
Is Estrella Immunopharma Inc. stock oversold or undervaluedQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Is Estrella Immunopharma Inc. reversing from oversold territoryJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com
Is Estrella Immunopharma Inc. building a consolidation basePortfolio Value Report & AI Powered Buy/Sell Recommendations - newser.com
Is Estrella Immunopharma Inc. stock ready for breakoutJuly 2025 Institutional & Consistent Profit Alerts - newser.com
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either? - Barchart.com
Estrella Immunopharma's (ESLA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat
Check out these key findings about Estrella Immunopharma Inc (ESLA) - setenews.com
Using data models to predict Estrella Immunopharma Inc. stock movementQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Given “Buy” Rating at D. Boral Capital - Defense World
Analyst Jason Kolbert Maintains Buy Rating on ESLA | ESLA Stock News - GuruFocus
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - BioSpace
Estrella Immunopharma stock soars after 100% complete response rate in trial - Investing.com Australia
Is now a turning point for Estrella Immunopharma Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com
Estrella Immunopharma, Inc. (ESLA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Will Estrella Immunopharma Inc. stock gain from government policiesSell Signal & Weekly Return Optimization Plans - newser.com
What indicators show strength in Estrella Immunopharma Inc.2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on Estrella Immunopharma Inc. performanceLayoff News & Safe Entry Point Alerts - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Estrella Immunopharma, Inc. (ESLA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Estrella Immunopharma Inc (ESLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.44%
0.70%
자본화:
|
볼륨(24시간):